Aim investors often prefer a hands-on chief executive. The boss at Bioventix (BVXP) certainly fits the bill. Peter Harrison joined medical equipment group KS Biomedix in the 1990s to head up its new antibodies division. When the company was taken over in 2003 he led the Bioventix buyout and took the group to the PLUS market (now NEX) in 2010.
At that point, he owned roughly a fifth of the company, but reduced the stake to 17 per cent by the time Bioventix joined Aim in 2014 with an offer price of 577p. A share sale at 800p netted him close to £1m – perhaps justified by the relatively paltry £120,000 annual salary he paid himself that year. With the share price now up over 300 per cent since the IPO (80 per cent in the past year alone) Mr Harrison has rewarded himself with another disposal, this time to the tune of £1.94m. He still owns 8 per cent of the business.
Buys | |||||||
Company | Director | Date | No of shares | Price (p) | Value (£) | Holding (shares) | Holding (%) |
AEW UK REIT | Bim Sandhu | 24 Oct 17 | 75,000 | 100.5 | 75,375 | 650,000 | 0.429 |
Aberdeen Asian Income Fund | Ian Cadby | 24 Oct 17 | 7,000 | 219.75 | 15,383 | 7,000 | 0.004 |
Aberdeen Asian Income Fund | Peter Arthur (ch) | 23 Oct 17 | 457 | 219 | 1,001 | 56,962 | 0.031 |
Amerisur Resources | Alex Snow | 23 Oct 17 | 500,000 | 19 | 95,000 | 500,000 | 0.041 |
Augean | Jim Meredith (ch) | 23 Oct 17 | 100,000 | 28 | 28,000 | 600,000 | 0.583 |
Augean | Jim Meredith (ch) | 24 Oct 17 | 100,000 | 30 | 30,000 | 700,000 | 0.681 |
Augean | Jim Meredith (ch) | 25 Oct 17 | 800,000 | 31 | 248,000 | 1,500,000 | 1.459 |
B.P. Marsh & Partners♥ | Brian Marsh (ch) | 23 Oct 17 | 20,000 | 257 | 51,400 | 18,024,401 | 61.745 |
B.P. Marsh & Partners | Stephen Clarke | 23 Oct 17 | 5,000 | 257 | 12,850 | 5,000 | 0.017 |
Bluejay Mining | Peter Waugh | 19 Oct 17 | 40,385 | 18.42 | 7,439 | 40,385 | 0.005 |
CPP | Mark Hamlin | 23 Oct 17 | 500,000 | 13 | 65,000 | 500,000 | 0.058 |
Franchise Brands | David Poutney | 23 Oct 17 | 91,000 | 58.5 | 53,235 | 2,209,970 | 2.843 |
Franchise Brands♥ | Nigel Wray | 23 Oct 17 | 92,000 | 58.5 | 53,820 | 21,720,120 | 27.942 |
Franchise Brands | Stephen Hemsley (ch) | 23 Oct 17 | 46,000 | 58.5 | 26,910 | 20,594,117 | 26.494 |
Franchise Brands♥ | Stephen Hemsley (ch) | 23 Oct 17 | 46,000 | 58.5 | 26,910 | 20,640,117 | 26.553 |
Homeserve | Katrina Cliffe | 20 Oct 17 | 6,034 | 823.75 | 49,705 | 12,076 | 0.004 |
Homeserve | Katrina Cliffe | 20 Oct 17 | 6,042 | 822.5 | 49,695 | 6,042 | 0.002 |
Homeserve* | Edward Fitzmaurice | 19 Oct 17 | 781,000 | 820 | 6,404,200 | 786,265 | 0.240 |
Keras Resources* | Brian Moritz (ch) | 24 Oct 17 | 16,793,845 | 0.375 | 62,977 | 42,627,178 | 1.885 |
Keras Resources* | Dave Reeves | 24 Oct 17 | 21,333,333 | 0.375 | 80,000 | 353,925,051 | 15.648 |
London Stock Exchange | David Nish | 20 Oct 17 | 515 | 3879 | 19,977 | 1,065 | 0.000 |
Low & Bonar♥ | Mike Powell | 19 Oct 17 | 14,000 | 70.896 | 9,925 | 39,000 | 0.012 |
Merlin Entertainments♥ | Anne-Francoise Nesmes (cfo) | 19 Oct 17 | 5,500 | 368.6 | 20,273 | 10,000 | 0.001 |
Merlin Entertainments | Ken Hydon | 23 Oct 17 | 30,000 | 375.7 | 112,710 | 61,920 | 0.006 |
Monks Investment Trust (The) | Belinda Richards | 24 Oct 17 | 2,674 | 744 | 19,895 | 2,674 | 0.001 |
Norish | Timothy O'Neill (ch) | 25 Oct 17 | 50,000 | 46.5 | 23,250 | 3,000,000 | 10.013 |
PCF | Mark Brown | 25 Oct 17 | 55,000 | 28 | 15,400 | 135,000 | 0.064 |
Parity | Alan Rommel (ceo) | 20 Oct 17 | 200,000 | 8.5 | 17,000 | 410,632 | 0.402 |
Pendragon | Chris Chambers (ch) | 24 Oct 17 | 510,000 | 22.99 | 117,249 | 2,000,000 | 0.140 |
Pendragon | Trevor Finn (ceo) | 24 Oct 17 | 2,000,000 | 22.25 | 445,000 | 16,716,623 | 1.172 |
Primorus Investments | Donald Strang | 24 Oct 17 | 4,410,000 | 0.218 | 9,614 | 4,410,000 | 0.192 |
Primorus Investments | Donald Strang | 25 Oct 17 | 1,163,235 | 0.22 | 2,559 | 5,573,235 | 0.243 |
Proteome Sciences♥ | Martin Diggle | 19 Oct 17 | 193,100 | 3.15 | 6,083 | 54,893,335 | 18.596 |
Proteome Sciences♥ | Martin Diggle | 20 Oct 17 | 119,636 | 3.15 | 3,769 | 55,012,971 | 18.637 |
Proteome Sciences♥ | Martin Diggle | 24 Oct 17 | 75,000 | 3.11 | 2,333 | 55,087,971 | 18.662 |
Proteome Sciences♥ | Martin Diggle | 25 Oct 17 | 109,460 | 3.25 | 3,557 | 55,197,431 | 18.699 |
Standard Life Investments Property Income Trust Lt | James Clifton-Brown | 24 Oct 17 | 21,500 | 91.69 | 19,713 | 21,500 | 0.005 |
Stilo International | David Ashman (ch) | 25 Oct 17 | 400,000 | 4.75 | 19,000 | 13,712,000 | 12.035 |
TOC Property Backed Lending Trust* | Douglas Noble | 19 Oct 17 | 3,000 | 100 | 3,000 | 8,600 | 0.038 |
TOC Property Backed Lending Trust* | Stephen Coe (ch) | 19 Oct 17 | 15,000 | 100 | 15,000 | 45,000 | 0.198 |
Sells | |||||||
Company | Director | Date | No of shares | Price (p) | Value (£) | Holding (shares) | Holding (%) |
Bioventix♥ | Ian Nicholson (ch) | 19 Oct 17 | 2,500 | 2,400.75 | 60,019 | 18,000 | 0.350 |
Bioventix | Ian Nicholson (ch) | 19 Oct 17 | 2,500 | 2,400.75 | 60,019 | 20,500 | 0.399 |
Bioventix | Peter Harrison (ceo) | 19 Oct 17 | 80,000 | 2,425 | 1,940,000 | 428,176 | 8.332 |
Churchill China | James Roper | 19 Oct 17 | 10,000 | 1,100 | 110,000 | 1,034,835 | 9.446 |
Gocompare.com | Peter Wood (ch) | 19 Oct 17 | 21,334,673 | 100 | 21,334,673 | 107,274,982 | 25.644 |
London Stock Exchange | Xavier Rolet (ceo) | 20 Oct 17 | 17,232 | 3870 | 666,878 | 530,356 | 0.153 |
London Stock Exchange | Xavier Rolet (ceo) | 20 Oct 17 | 100,000 | 3,860.70 | 3,860,705 | 430,356 | 0.124 |
London Stock Exchange | Xavier Rolet (ceo) | 25 Oct 17 | 100,000 | 3,799.89 | 3,799,890 | 330,356 | 0.095 |
Produce Investments | Neil Davidson (ch) | 20 Oct 17 | 130,400 | 192 | 250,368 | 0 | 0.000 |
Robert Walters | Giles Daubeney | 20 Oct 17 | 100,000 | 590 | 590,000 | 1,633,069 | 2.191 |
Sirius Real Estate | Andrew Coombs (ceo) | 19 Oct 17 | 218,261 | 61.523 | 134,281 | 4,383,064 | 0.473 |
WH Smith♥ | Robert Moorhead (fd) | 24 Oct 17 | 25,000 | 2,034.74 | 508,684 | 227,676 | 0.206 |
* placing/tender/open offer ♥ spouse/connected party |